ARSUF (Fagron) Current Deferred Revenue : $0.0 Mil (As of Dec. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Fagron Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Fagron's current deferred revenue for the quarter that ended in Dec. 2024 was $0.0 Mil.

Fagron Current Deferred Revenue Historical Data

The historical data trend for Fagron's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fagron Current Deferred Revenue Chart

Fagron Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Current Deferred Revenue

Get a 7-Day Free Trial

Fagron Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Current Deferred Revenue	Get a 7-Day Free Trial															-	-	-	-	-

Fagron Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Fagron's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Fagron Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fagron SA (OTCPK:ARSUF) » Definitions » Current Deferred Revenue

Comparable Companies

Traded in Other Exchanges

0HNZ:UK 4A5:Germany FAGR:Belgium

Address

Fascinatio Boulevard 350, Rotterdam, ZH, NLD, 3065 WB

Website

https://www.fagron.com

Fagron SA is a pharmaceutical compounding company operating in Belgium. It acts as a supplier of pharmaceutical care to hospitals, pharmacies, clinics, and patients across the world. The company also produces pharmaceutical raw materials, equipment, and supplies that are needed to prepare medication in the pharmacy. Its segments are namely Fagron Europe, Middle East and Africa (EMEA), Fagron North America, and Fagron Latin America. The majority of its revenue comes from Fagron North America.